death Ventilators patient

NHS gets breakthrough new Covid drug that slashes death rate by up to half

Reading now: 515
www.mirror.co.uk

Two existing drugs have been shown to cut the chances of ventilated Covid-19 patients dying by almost half. The findings from a world-leading NHS clinical trial could save thousands of lives of people who end up needing oxygen.

The latest result of the 4,000-patient Recovery trial showed that using arthritis drug tocilizumab reduced death rates by 15%.

Taken alongside dexamethasone - the first drug previously shown to save lives of Covid patients - the benefit was even higher.

Read more on mirror.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News